Nicholas J. Sarlis
Directeur Technique/Scientifique/R&D chez Sellas Life Sciences Group Ltd.
Profil
Nicholas J.
Sarlis is currently the Chief Medical Officer & Senior Vice President at Sellas Life Sciences Group Ltd.
He previously worked as the Vice President & Head-Global Medical Affairs at Incyte Corp.
from 2010 to 2016.
Prior to that, he was an Associate Professor at The University of Texas M.D.
Anderson Cancer Center from 2002 to 2006 and later returned to the same institution as an Associate Professor.
He also served as the Chief Medical Officer & Executive Vice President at SELLAS Life Sciences Group, Inc. from 2017 to 2020.
Sarlis earned his doctorate from the University of London in 1992 and his undergraduate and another doctorate degree from National & Kapodistrian University of Athens in 1988 and 1989, respectively.
Postes actifs de Nicholas J. Sarlis
Sociétés | Poste | Début |
---|---|---|
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Nicholas J. Sarlis
Sociétés | Poste | Fin |
---|---|---|
SELLAS LIFE SCIENCES GROUP, INC. | Directeur Technique/Scientifique/R&D | 01/03/2020 |
INCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 01/05/2016 |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01/01/2006 |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Formation de Nicholas J. Sarlis
National & Kapodistrian University of Athens | Doctorate Degree |
University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
INCYTE CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |